ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

XERS Xeris Biopharma Holdings Inc

1.75
0.00 (0.00%)
29 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Xeris Biopharma Holdings Inc XERS 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 1.75 09:00:00
개장가 저가 고가 종가 전일 종가
1.75
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
04/04/202405:05BWXeris Pharmaceuticals Announces Inducement Grants Under..
02/04/202420:00BWXeris Biopharma to Participate in the 23rd Annual Needham..
07/03/202406:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/03/202406:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/03/202421:27EDGAR2Form 8-K - Current report
06/03/202421:02BWXeris Biopharma Reports Fourth Quarter and Full Year 2023..
06/03/202421:00BWXeris Refinances Its $150M Senior Secured Term Loan Facility..
28/02/202421:00BWXeris Biopharma to Report Fourth Quarter and Full Year 2023..
05/02/202421:00BWXeris to Present at the Oppenheimer 34th Annual Healthcare..
01/02/202407:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202400:12DJNXeris Biopharma Shares Climb 12% on Amgen License Agreement
10/01/202422:53DJNXeris Biopharma Reaches License Agreement With Amgen On..
10/01/202422:00BWXeris Biopharma Enters Into an Exclusive Worldwide License..
06/01/202406:05BWXeris Pharmaceuticals Announces Inducement Grants Under..
04/01/202421:09EDGAR2Form 8-K - Current report
04/01/202421:00BWXeris Biopharma Updates Its Outlook for 2023
27/12/202321:00BWXeris Biopharma to Present at the 42nd Annual J.P. Morgan..
22/11/202306:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202306:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202321:20EDGAR2Form 8-K - Current report
09/11/202321:00BWXeris Biopharma Reports Third Quarter 2023 Financial Results
16/10/202320:12EDGAR2Form 8-K - Current report
16/10/202320:00BWXeris Biopharma Raises Full-Year Financial Guidance and..
30/09/202305:55EDGAR2Form 8-K - Current report
27/09/202321:11EDGAR2Form 8-K - Current report
27/09/202321:00BWXeris Biopharma Announces Private Convertible Note Exchange..
15/09/202305:05BWXeris to Participate in the 2023 Cantor Global Healthcare..
28/08/202320:00BWXeris to Participate at the H.C. Wainwright 25th Annual..
09/08/202305:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202320:23EDGAR2Form 8-K - Current report
08/08/202320:00BWXeris Biopharma Reports Second Quarter 2023 Financial..
01/08/202320:00BWXeris Biopharma to Report Second Quarter 2023 Financial..
31/07/202320:00BWXeris Ships One Millionth Gvoke® Unit
29/06/202305:28EDGAR2Form 8-K - Current report
21/06/202320:00BWXeris Biopharma Announces First Participant Dosed in a Phase..
01/06/202320:00BWXeris Biopharma to Participate at the Jefferies Healthcare..
09/05/202320:00BWXeris Biopharma Reports First Quarter 2023 Financial Results
02/05/202320:00BWXeris Biopharma to Report First Quarter 2023 Financial..

최근 히스토리

Delayed Upgrade Clock